Viemed Q2 net revenue $63.1M (record, +14.7% YoY); diluted EPS $0.08 vs $0.04

VIEMED HEALTHCARE, INC.

2025-Q2 EPS reported $0.14 revenue$122,185,000

Net revenues for Q2 2025 hit $63.1M, a record high, up 14.7% from $55.0M in Q2 2024.
Net income attributable to Viemed $3.2M ($0.08 diluted EPS) vs $1.5M ($0.04) YoY, +115.1%.
Adjusted EBITDA $14.3M, up 11.5% over the prior year quarter.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.